Mitolyns' recent withdrawal from the market has sent ripples throughout the industry. Its consequences on both consumers and rivals are still emerging, but initial indications suggest a period of significant transformation. The long-term outlook remains ambiguous, pending further developments in the market. *Analysts{ speculate that Mitolyns' depa